Prophylactic intermittent treatment with inhaled corticosteroids of asthma exacerbations due to airway infections in toddlers
- PMID: 10090546
- DOI: 10.1080/08035259950170583
Prophylactic intermittent treatment with inhaled corticosteroids of asthma exacerbations due to airway infections in toddlers
Abstract
The aim of this study was to investigate whether budesonide, for 10 d, administered at the first sign of an upper respiratory tract infection, could reduce asthma symptoms in 1-3-y-old children with asthma during infections. The primary efficacy variable was symptom scores. The study had a multicentre, randomized, double-blind, placebo-controlled design with parallel groups. Fifty-five children with a mean age of 26 months received either budesonide or placebo via a spacer with a facemask. Each child was monitored for 1 y. Budesonide was given 400 microg q.i.d. for the first 3 d and b.i.d. for 7 d. Symptoms (cough, wheeze, noisy breathing and breathlessness) were scored (0-3) daily by the parents. Asthma symptom scores were lower in children treated with budesonide than in those given placebo. The effect was most pronounced for cough and noisy breathing, but it did not affect the need for hospital care. In conclusion, treatment with budesonide, started at the first sign of a respiratory infection, reduced asthma symptoms in toddlers with episodic asthma.
Similar articles
-
Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial.JAMA. 1999 Jun 9;281(22):2119-26. doi: 10.1001/jama.281.22.2119. JAMA. 1999. PMID: 10367823 Clinical Trial.
-
Prevention of viral induced asthma attacks using inhaled budesonide.Arch Dis Child. 1993 Jan;68(1):85-7. doi: 10.1136/adc.68.1.85. Arch Dis Child. 1993. PMID: 8435016 Free PMC article. Clinical Trial.
-
A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma.Clin Ther. 2006 Jun;28(6):906-20. doi: 10.1016/j.clinthera.2006.06.014. Clin Ther. 2006. PMID: 16860173 Clinical Trial.
-
Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.J Asthma. 2010 May;47(4):447-59. doi: 10.3109/02770901003725684. J Asthma. 2010. PMID: 20528601 Review.
-
Use of Oral Corticosteroids in the Wheezy Toddler.J Pediatr. 2018 Oct;201:16-20. doi: 10.1016/j.jpeds.2018.06.011. Epub 2018 Jun 29. J Pediatr. 2018. PMID: 30251636 Review. No abstract available.
Cited by
-
Daily or intermittent budesonide in preschool children with recurrent wheezing.N Engl J Med. 2011 Nov 24;365(21):1990-2001. doi: 10.1056/NEJMoa1104647. N Engl J Med. 2011. PMID: 22111718 Free PMC article. Clinical Trial.
-
Diagnosing asthma in young children.Curr Allergy Asthma Rep. 2002 Nov;2(6):447-52. doi: 10.1007/s11882-002-0083-1. Curr Allergy Asthma Rep. 2002. PMID: 12359114 Review.
-
The use of inhaled corticosteroids in pediatric asthma: update.World Allergy Organ J. 2016 Aug 12;9:26. doi: 10.1186/s40413-016-0117-0. eCollection 2016. World Allergy Organ J. 2016. PMID: 27551328 Free PMC article. Review.
-
Inhaled steroids for episodic viral wheeze of childhood.Cochrane Database Syst Rev. 2000;2000(2):CD001107. doi: 10.1002/14651858.CD001107. Cochrane Database Syst Rev. 2000. PMID: 10796596 Free PMC article. Review.
-
Pharmacotherapy--treatment of intermittent asthma with ICSs.CMAJ. 2005 Sep 13;173(6 Suppl):S33-6. CMAJ. 2005. PMID: 16157734 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical